Clin2
NCT07159087Possibly a fitEnrolling by invitation

New drug balloon for re-narrowed stents

Coronary Arterial Disease (CAD)

Part of Heart & circulation clinical trials.

This trial tests a new drug-coated balloon (Genoss SCB) versus an existing one (SeQuent Please NEO) for people whose heart stents have re-narrowed. It aims to see which balloon better keeps the artery open.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
94 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You must be 19 years of age or older.
  • You have a stent that has re-narrowed (in-stent restenosis) happening at least 90 days after it was placed.
  • You may have stable chest pain, unstable chest pain, a small heart attack (NSTEMI), or silent ischemia, but not a STEMI heart attack.
  • Women who can get pregnant need to use effective birth control during the study.
  • One or two narrowed areas inside a stent will be treated, and the narrowed segment must be shorter than 36 mm.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07444957Recruiting
Safety of a drug-coated balloon for heart artery blockages

This study tests a special balloon coated with a drug called sirolimus to open blocked heart arteries. It may be an option for people with coronary artery disease who need a less invasive treatment.

Vigo, Pontevedra
NCT06822712Recruiting
Sirolimus-coated balloon for heart artery branch blockages

This trial tests a new balloon coated with sirolimus (a drug that helps prevent re-blockage) for treating blocked arteries at branch points (bifurcations) in the heart. If you have a blocked artery at a branch point, this study may offer a way to treat the side branch without placing a stent there.

Lanzhou, Gansu
NCT06866756Recruiting
Comparing two drug-coated balloons for heart artery treatment

This trial is comparing sirolimus and paclitaxel drug-coated balloons to treat new blockages or restenosis (re-blockage) in heart arteries. It aims to see which type of balloon works better for opening arteries without leaving a metal stent behind.

Vigo, Pontevedra
NCT06669793Not yet recruiting
New balloon treatment for large heart artery blockages

This study tests a special balloon coated with a medicine (Biolimus) to open new blockages in large heart arteries. The goal is to see if it works well as an alternative to a stent for people with certain blockages.

NCT05438121Recruiting
Tests a drug-coated balloon to stabilize clogged heart arteries

This trial studies whether a drug-coated balloon can better treat new, narrowed spots in multiple coronary arteries and “stabilize” the plaque. It may help improve blood flow after a procedure called balloon angioplasty for selected patients.

Ansan-si, Gyeonggi-do
NCT06086496Enrolling by invitation
Study of a new drug-releasing stent for heart arteries

This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.

Seoul, Seoul

Hear when a new Coronary Arterial Disease (CAD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.